Hepatic Encephalopathy: Symptoms, Treatment and Safety

This guide is for adults and the people supporting them. It explains hepatic encephalopathy, the reasons for urgent assessment, and the everyday treatment decisions to discuss with a liver team. It cannot identify the cause of a reader’s symptoms or replace an individual care plan.

Recognizing changes in thinking and behavior

Hepatic encephalopathy, often shortened to HE, is impaired brain function related to liver disease. It can affect thinking, emotions, movement, and daily activities. Someone who usually follows conversations easily may lose the thread, forget recent information, or struggle to complete familiar tasks. Their sleep pattern or personality may change. Coordination can become less reliable, making ordinary activities harder. These changes can fluctuate: a relatively clear conversation at one moment does not explain away a concerning change earlier in the day. Family members sometimes notice the difference before the person recognizes that anything is wrong. ²⁷

The range is broad, from subtle problems with concentration to pronounced confusion or reduced consciousness. A single symptom such as tiredness is not enough to identify HE. What matters is the pattern, its effect on usual function, and the medical assessment that follows. Treatment can improve symptoms, but recovery is not identical for everyone. The underlying illness and severity of the episode matter, and returning home does not necessarily mean that thinking and coordination have immediately returned to their previous level. ²⁷

A quiet or withdrawn person may still be seriously unwell

Confusion does not always look restless or agitated. A person may become unusually quiet, slow to respond, withdrawn, or less interested in eating and moving. This quieter pattern, called hypoactive delirium, can be overlooked because the person seems easier to care for. Relatives can help by describing a specific change from normal, rather than simply saying that the person is not themselves. For example, the team needs to know when slower responses began and whether alertness has varied during the day. ²²

Delirium describes a disturbance of attention and awareness with an acute or fluctuating course; it is not another name for HE. Clinicians still look for its causes. Familiar voices, reassurance, orientation to the surroundings, and access to needed glasses or hearing aids can support care. These measures help the person engage with assessment, but do not replace investigation or treatment of the illness causing the change. ²²

Covert, overt, episodic, and persistent HE

Clinicians classify HE in several ways because severity alone does not describe the whole problem. Type A accompanies acute liver failure. Type B is associated predominantly with blood bypassing the liver through a portosystemic shunt. Type C occurs with cirrhosis. The labels explain the setting; they are not successive stages that everyone passes through. A clinician also records whether a trigger has been identified and whether symptoms occur in separate episodes, recur, or remain persistently present between exacerbations. ¹

Covert HE includes minimal HE and West Haven grade I. Minimal HE involves deficits found through suitable cognitive or neurophysiological testing rather than obvious abnormalities on a routine examination. Overt generally describes grades II to IV, ranging from clear disorientation to coma. Grading is a clinical assessment, not a home checklist or a blood-test score. A flapping movement of the hands, called asterixis, can be a useful examination finding, but is neither specific to HE nor a defining feature of minimal disease. An absent hand flap does not establish that thinking is normal. ¹

Why hepatic encephalopathy develops

The gut, liver, and brain are connected through the circulation. Substances produced during digestion and by intestinal microbes normally pass through the liver for processing. Ammonia is one important example. When liver function is impaired, or blood is diverted around the liver, more of these substances can reach the general circulation. Their effects on brain function interact with inflammation and other changes in the body. This is why HE cannot be reduced to a simple statement that one toxin has crossed one numerical threshold. ⁹

The same person may be more vulnerable during an infection, another metabolic disturbance, or exposure to medicines that depress brain activity. Gut transit and the intestinal microbial environment also matter. This helps explain why treatment has several parts: reducing the gut-related burden, correcting contributing illness, and reassessing other possible explanations for altered thinking. A diagnosis of cirrhosis makes HE a possibility, but does not protect someone from a stroke, seizure, intracranial bleeding, or another cause of confusion. ⁹

Why an episode can follow a stable period

An overt episode may develop over hours or days after a period when the person seemed stable. Infection, bleeding into the digestive tract, constipation, alcohol-related problems, or disturbances in blood salts can precipitate deterioration. A trigger may be less obvious than expected: the clinical team has to look for it rather than assuming that the latest change in bowel movements explains everything. Several contributors may be present at the same time, and sometimes no single precipitant is identified. ²⁸

Treating the precipitant is central to recovery. Bowel-directed medicine cannot by itself resolve an infection or control gastrointestinal bleeding. Conversely, treating a trigger does not mean the team can ignore the effects on thinking and consciousness. Assessment and treatment therefore proceed together. The useful question after an episode is not only Which HE medicine worked? but also What brought this on, and what does that change about the next care plan? ²⁸

Medicines deserve a careful review

Sedating medicines can complicate HE or make a change in mental state harder to interpret. The review may include sleeping tablets, benzodiazepines, opioid pain medicines, and other drugs that affect alertness. Diuretics are different: they may be important for fluid accumulation, but excessive fluid loss can create problems. The team needs the complete list, including nonprescription products, recent dose changes, including changes made during a recent hospital stay, and medicines borrowed from someone else. Alcohol use and changes in drinking also matter to the assessment. ⁶

A medicine can be useful for one liver-related problem while needing adjustment during another. That is a reason for an individualized review, not a reason to stop every prescription thought to carry a risk. Ask the prescriber or pharmacist to reconcile the list and explain which products to avoid, which to continue, and what should trigger a call. Bring that updated list whenever urgent care is needed. ⁶

How clinicians assess suspected HE

HE is a clinical diagnosis made in the context of liver disease or abnormal blood shunting, while considering other explanations for brain dysfunction. The assessment includes the time course, level of awareness, neurological examination, recent illnesses, and information from someone who knows the person’s usual behavior. Tests are selected to investigate likely triggers and alternatives. A prior HE diagnosis is useful history, but does not prove that a new episode has the same cause as the previous one. ²

Brain imaging may be needed when the diagnosis is uncertain, there are features suggesting another neurological problem, or the response to treatment is unexpected. No CT or MRI finding establishes HE by itself. Equally, not every familiar episode requires the same imaging tests. The European Association for the Study of the Liver recommends measuring plasma ammonia in a person with liver disease and delirium because a normal result makes the diagnosis less convincing and calls for reconsideration. The decision remains clinical, using the whole assessment rather than one result in isolation. ²

What testing for covert HE can reveal

Testing for minimal HE looks for difficulty that may not be apparent in ordinary conversation. One studied approach, the Stroop EncephalApp, uses a timed cognitive task; other approaches include the Psychometric Hepatic Encephalopathy Score and an inhibitory-control test. A multicenter U.S. validation study compared these methods in outpatients with cirrhosis and controls. The investigators used population norms adjusted for age, sex, and education, illustrating why a result needs appropriate reference values rather than interpretation as a simple pass-or-fail game. ³²

The different comparison methods did not identify exactly the same proportion of patients as impaired, and test sensitivity was not perfect. This means that one result cannot be treated as a universal answer across every clinical setting. In that study, performance also helped identify people who later developed overt HE, but prediction did not mean certainty for an individual. Clinicians use the findings in the context of the person’s symptoms and disease. An unreviewed phone-app score is not a basis for self-diagnosis or deciding that driving is safe. ³²

Why an ammonia level is not a severity score

Ammonia is involved in HE, but its blood concentration does not consistently match the degree of confusion. A high result alone cannot establish the diagnosis or assign a West Haven grade. Collection, transport, processing, and laboratory methods can influence the measurement. This makes it particularly risky to compare isolated numbers without knowing how the samples were handled or what was happening clinically. A person can improve without a neatly parallel fall in the reported value. ⁸

AASLD guidance emphasizes that HE in chronic liver disease is diagnosed and followed clinically, rather than through routine ammonia-directed decisions. This differs in emphasis from EASL’s recommendation to include a measurement in the initial assessment of delirium. Both approaches require attention to alternative diagnoses when the result is normal. Normal ammonia is not a stand-alone guarantee that all is well, and an elevated value is not a home-treatment instruction. Changes in alertness and function matter more than trying to achieve a particular laboratory number. ⁸

Treating the current episode

Hospital care first establishes how safely the person can breathe, swallow, and protect their airway, alongside assessment of the cause. Markedly impaired consciousness may require a higher level of monitoring and support. Treatment addresses triggers and overt HE together. The 2026 American College of Gastroenterology guideline recommends lactulose for overt HE and conditionally suggests adding rifaximin during an acute episode. The acute add-on recommendation has low-certainty evidence; it is distinct from the drug’s U.S. recurrence-reduction indication. ³

The team follows mental status and the overall clinical course, rather than assuming that more bowel movements automatically mean recovery. An atypical course or inadequate response prompts reassessment for another illness, an unresolved precipitant, or relevant shunting. The same guideline also supports specialist-directed rifaximin prevention around elective TIPS procedures. These are decisions made within a clinical plan. They do not provide a reason to start leftover antibiotics, copy a hospital regimen at home, or postpone emergency evaluation while trying an extra medicine. ³

What lactulose is intended to do

Lactulose is a sugar-based medicine that reaches the colon and changes its environment, helping reduce the amount of ammonia available for absorption. It also changes bowel movements. For HE, the prescription is aimed at the condition’s gut-related mechanisms, rather than simply treating ordinary constipation. This explains why a person who is already passing stool may still be prescribed lactulose and why it may remain part of care after obvious confusion has settled. The purpose and instructions should be clear to both the patient and anyone helping with medicines. ¹⁰

The actual product matters. Lactulose solutions may contain other sugars, and certain dietary or metabolic conditions require specific advice; a required low-galactose diet is a relevant contraindication in U.S. labeling. Excessive diarrhea can disturb fluid and electrolyte balance. Someone with reduced consciousness may also be unable to take an oral medicine safely. These considerations belong in prescribing and clinical assessment. They are reasons to check the exact medicine and care plan, rather than improvising an oral or rectal treatment regimen. ¹⁰

Soft stools are the goal; profuse diarrhea is a problem

A commonly used lactulose target is about two to three soft bowel movements daily, adjusted by the clinical team to the individual’s response. Soft is important. Counting trips to the toilet without considering stool consistency can encourage too much treatment. Frequent watery stools do not provide extra assurance against HE. They can cause fluid loss and contribute to dehydration, which may itself increase the risk of another episode. The stool pattern and the person’s cognition need to be considered together. ²⁹

Tell the team if the agreed target is not being reached, if diarrhea is persistent, or if the plan is difficult to follow. The response may involve reviewing the prescription and the broader clinical picture, rather than simply pushing the dose upward. Similarly, reaching the stool target does not explain away new confusion or sleepiness. A useful review considers whether bowel movements are comfortable and manageable, whether there are signs of excessive fluid loss, and whether the person’s everyday thinking is improving. ²⁹

Making prescribed lactulose easier to take

Measure liquid lactulose with the device supplied or recommended by a pharmacist; a household spoon may not give an accurate amount. Follow the prescribed schedule, and ask what to do about missed doses rather than guessing. Bloating, wind, nausea, and diarrhea can make regular treatment difficult. These effects deserve a conversation, especially when they are causing the person to avoid doses. The prescriber may be able to adjust the practical plan without losing sight of why the medicine was prescribed. ¹²

Persistent diarrhea can disturb potassium and other aspects of fluid balance, so report continuing or troublesome symptoms. A pharmacist can help with product-specific questions, measuring equipment, and how to take the prescribed medicine. Follow any individualized fluid advice from the liver team instead of applying a generic instruction to drink unlimited water. Advice for routine constipation about waiting several days for improvement does not apply to a new acute change in mental state. ¹²

Why rifaximin may be added

Rifaximin is an antibiotic used in HE care for its effects within the intestine. The U.S. Xifaxan indication is to reduce recurrence of overt HE in adults. Most participants in the pivotal recurrence study also took lactulose, so this evidence should not be interpreted as a reason for everyone to replace lactulose with rifaximin. The clinician decides how the medicines fit together, taking account of previous episodes, tolerability, and the individual treatment plan. Rifaximin prescribed for HE does not replace treatment of a separate infection elsewhere in the body. ¹¹

Low intestinal absorption does not mean there are no adverse effects or interactions. The U.S. label warns about rifamycin allergy and potentially serious antibiotic-associated diarrhea, including C. difficile infection. Stop the medicine and call emergency services for facial or throat swelling or difficulty breathing. Exposure can be higher in severe liver impairment. Medicines such as strong P-glycoprotein inhibitors require attention, and people taking warfarin may need closer monitoring. Report persistent or worsening diarrhea and give the prescriber the full medicine list. A new symptom should not automatically be attributed to the underlying liver disease. ¹¹

Country-specific labeling and warning signs

The current UK rifaximin 550 mg product information also concerns reducing recurrent overt HE in adults. It includes cautions and contraindications that must be checked against the particular product and patient, including intestinal obstruction. Product names, approved uses, and warning language can differ between countries. A guideline recommendation is not the same thing as a regulatory indication, and neither removes the need to assess an individual’s risks. ²⁴

The UK information includes serious skin-reaction warnings. A new severe rash, blistering, peeling skin, or sores affecting the mouth or other mucosal surfaces requires stopping rifaximin and seeking urgent medical help. Do not restart it unless the treating clinician specifically advises that it is safe. Make sure the team knows when rifaximin was started and what other medicines were taken. Do not wait for a routine appointment to discuss a potentially serious reaction. ²⁴

NICE recommends rifaximin within its marketing authorization as an option for reducing recurrent overt HE in adults. This is UK appraisal guidance, not an international approval for every proposed use. ¹³

Reducing the chance of another episode

Resolution of an episode and prevention of another episode are different goals. A person may feel clearer while still needing the treatment prescribed to reduce recurrence. The October 2026 ACG preventive-care guideline supports continuing rifaximin added to lactulose after hospital discharge and adding it for recurrent overt HE in outpatients. This does not make every patient’s regimen identical. Breakthrough symptoms should prompt reassessment of the illness and the practical treatment plan, rather than being dismissed as something inevitable. ⁴

Prevention also needs to be distinguished from treating someone who has never had overt HE. The same guidance suggests lactulose for minimal HE, but does not support indiscriminate rifaximin primary prevention. Cognitive complaints therefore need appropriate assessment before a medicine is chosen. Starting an antibiotic for nonspecific brain fog is not a substitute for determining its cause. When continuing treatment, the care team should explain which problem the medicine is addressing and review the plan as circumstances change. ⁴

Nutrition and muscle health are part of treatment

Routine protein restriction is not recommended for HE. People with cirrhosis need adequate protein and energy, and unnecessary restriction can worsen nutrition rather than solve the problem. Preserving muscle is important because advanced liver disease can make it difficult to maintain strength and body reserves. Avoid interpreting the gut’s role in ammonia production as a reason to stop eating protein. The practical goal is enough nourishment from foods the person can tolerate and obtain, with specialist advice where intake is difficult. ¹⁴

Vegetable and dairy proteins can be useful parts of the diet, but no single food group needs to be treated as a universal cure. A dietitian can help distribute appropriate choices across the day and adapt them to other medical needs. Broad food bans may leave someone eating too little, especially when appetite is already poor. Restriction should have a specific clinical reason and a workable replacement plan. Nutritional assessment is more useful than trying to follow a long list of supposedly forbidden foods. ¹⁴

Muscle loss may be hidden by body weight

A person can lose muscle while their weight appears stable or high. Obesity and fluid accumulation can obscure changes in body composition, so a scale alone is an incomplete measure of nutrition. Frailty describes reduced physical reserve and function; it overlaps with, but is not identical to, loss of muscle mass. Clinicians may assess strength, walking or other functional abilities, food intake, and changes over time. These findings can reveal support needs that are not obvious from appearance. ¹⁵

Nutrition and rehabilitation plans should match the person’s current capability and illnesses. A dietitian, physiotherapist, or other trained professional can help identify safe ways to maintain activity and improve intake. Falls risk, fatigue, and day-to-day function matter when setting goals. Exercise is not something to attempt as treatment during an acute confused episode. After stabilization, reassessment can help adjust the plan as strength returns or if appetite, mobility, or liver disease changes. The aim is sustainable function rather than a demanding program that cannot be maintained. ¹⁵

Why fasting and nutrition tests need special interpretation

Advanced liver disease can reduce the stores of glycogen that normally help supply energy between meals. During fasting, the body may therefore turn to other fuels earlier, including amino acids derived from protein. This creates a metabolic reason to avoid prolonged gaps without nourishment, beyond the simple observation that someone has a poor appetite. Energy and protein needs have to be considered together: consuming protein while taking in too little overall energy may still leave the body breaking down its own reserves. ³⁰

A low albumin concentration cannot be interpreted as a stand-alone measure of how well someone is eating, because albumin is made by the liver and its concentration is influenced by the disease. Nutritional assessment brings together intake, examination, body composition, and function rather than relying on one laboratory number. Specific micronutrient deficiencies may also coexist with broader malnutrition. Replacement should address an identified need; supplements are not a general substitute for assessing the reasons for poor nutrition. ³⁰

Turning nutrition advice into achievable meals

Regular meals and snacks help reduce prolonged periods without nourishment. Smaller portions more often may be easier when appetite is low or a full meal feels overwhelming. Practical protein choices can include eggs, yogurt or other dairy foods, beans, lentils, tofu, fish, and meat according to preference and tolerance. A late snack may be part of the dietitian’s plan. The point is to make eating achievable throughout the day, not to impose an elaborate menu that the household cannot prepare. ¹⁶

Tell the team about early fullness, nausea, poor appetite, or difficulty buying and preparing food. These barriers need practical solutions before advice about nutrient targets can help. Diabetes or other conditions may change the best timing and composition of meals. If ordinary food is insufficient, a dietitian may recommend nutritional supplements suited to the person’s needs. Do not automatically adopt someone else’s supplement, salt limit, or fluid restriction; a suitable plan accounts for the individual’s intake, symptoms, and medical treatment. ¹⁶

When specialist review needs to go further

How a shunt can contribute

A portosystemic shunt provides a route for blood from the digestive organs to reach the wider circulation while bypassing some liver processing. Some shunts develop spontaneously in the setting of portal hypertension. A transjugular intrahepatic portosystemic shunt, or TIPS, is deliberately created to help selected pressure-related complications, such as difficult ascites or bleeding. Its potential benefit comes with a trade-off: diverted blood can carry more gut-derived substances into the systemic circulation. ²¹

This explains why HE may appear or worsen after TIPS, even when the procedure is helping the problem it was intended to treat. The relationship is not a reason to assume every post-procedure symptom is HE or that every shunt should be closed. The liver team needs to consider the overall circulation, the original reason for the procedure, and the current clinical course. ²¹

Repeated episodes require a fresh look

When HE persists or returns despite treatment, specialists revisit the circumstances rather than automatically adding more of the same medicine. In someone with a TIPS, the assessment considers liver function, kidney function, sodium balance, prior HE, age, and muscle health, alongside the severity of ongoing symptoms. Procedural decisions need to weigh the benefits of the shunt against its contribution to impaired thinking. This is often a multidisciplinary discussion because improving one complication can worsen another. ²⁰

Selected people with refractory post-TIPS HE may be considered for a procedure that reduces shunt flow. Other abnormal bypass vessels may also be relevant to specialist assessment. These approaches are not routine solutions for every episode. Reducing diversion may allow portal-hypertension problems, including ascites or bleeding, to return. The team should explain what improvement is realistically expected, what risks would reappear, and how the person would be followed afterward. Decisions depend on the anatomy, available liver reserve, and the broader treatment options. ²⁰

When transplant assessment enters the conversation

HE is a decompensating complication of cirrhosis, meaning that the disease has produced an important clinical consequence. Its first appearance is a reason to consider whether referral for liver transplant evaluation is appropriate. The conversation need not wait until every aspect of health has deteriorated. Referral allows a transplant service to assess the overall liver disease, other medical conditions, and the person’s circumstances. It is an evaluation, not a promise of eligibility or immediate transplantation. ¹⁹

Evaluation, acceptance for listing, and receiving an organ are separate steps. A person may need further testing, treatment, or support before a decision can be made. The referring liver team can explain the purpose of the referral and what questions the transplant service will address. An HE episode alone cannot determine an individual’s prognosis or the timing of a transplant. The decision belongs within an assessment of the whole person and their goals. ¹⁹

Acute liver failure has a different emergency pathway

HE can also occur with acute liver failure, a rapidly developing syndrome of severe liver dysfunction that is distinct from an episode in established cirrhosis. In acute liver failure, brain swelling is a major concern, and early involvement of a specialist or transplant center is important. Monitoring, treatment of the cause, and intensive supportive care may be needed urgently. Advice written for a person managing recurrent cirrhosis-associated HE at home cannot simply be transferred to this setting. ¹⁸

Ammonia can have a different prognostic and monitoring role in acute liver failure, so the limitations of routine ammonia-guided care in chronic cirrhosis should not be turned into a rule that the test is never useful. An acute HE episode in cirrhosis is also not automatically acute liver failure or acute-on-chronic liver failure; these terms describe different clinical syndromes. Specialists distinguish them using the background disease and the pattern of organ dysfunction. The terminology matters because the level of care and treatment priorities can differ. ¹⁸

For a broader explanation of these liver-failure syndromes, see the separate guide to liver failure warning signs and specialist care.

The underlying liver disease still needs treatment

HE medicines address one complication; they do not replace treatment of the cause of cirrhosis. Depending on that cause, care may include treatment of viral hepatitis, alcohol-related disease, or another liver disorder. Other complications also need continuing attention. A clearer mental state does not mean that bleeding risk, fluid problems, or infection concerns have disappeared. Keeping the broader liver plan active gives the team a better chance of addressing problems that can destabilize health again. ⁷

Check nonprescription medicines and herbal products with the liver team, because a product sold without a prescription is not automatically suitable for advanced liver disease. Discuss alcohol and nutritional needs openly so advice reflects the actual situation. Restrictions should be individualized rather than borrowed from a general liver-disease checklist. Vomiting blood or passing black, tar-like stool requires urgent hospital care. These symptoms must not be handled solely by adjusting HE treatment, even if altered thinking is present at the same time. ⁷

Living safely after an episode

Subtle cognitive impairment can affect physical safety

The word minimal can understate the everyday consequences of cognitive impairment. In a prospective study of 122 outpatients with cirrhosis, those with an abnormal Psychometric Hepatic Encephalopathy Score experienced more falls during follow-up than those without that finding. Falls in the impaired group also resulted in fractures and greater use of emergency and hospital care. The association was present even among participants who were not taking psychoactive medicines, so medication exposure did not fully explain the observation. ³³

This was a study of a particular outpatient population, not a calculation of every patient’s personal fall risk. It also did not establish that every fall was caused by HE or that improving a test score would necessarily prevent an injury. Its value is to show that subtle cognitive abnormalities can have consequences beyond memory complaints. Falls and near-falls are therefore relevant symptoms to report during assessment, particularly when they accompany changes in attention or everyday function. They should not be dismissed merely because the person remains conversationally alert. ³³

Driving rules depend on where you live

Do not drive while confused or cognitively impaired. Feeling better does not itself establish that attention and reaction are safe for driving, and licensing requirements differ between countries and vehicle categories. Seek advice from the liver specialist and the relevant licensing authority before returning to the road. General statements about whether a medicine causes drowsiness do not answer whether a person with HE is fit to drive. Planning alternative transport is part of making recovery workable. ¹⁷

In Great Britain, DVLA guidance says that people with overt HE must stop driving and notify the agency. Licensing may be considered six months after recovery, subject to a specialist report and the other required conditions; six months is not automatic clearance. Minimal HE has different rules for ordinary car or motorcycle licences and bus or lorry licences, and notification is still relevant. These are Great Britain-specific rules, not a worldwide waiting period. Check the current requirements for the person’s actual jurisdiction and licence. ¹⁷

Why a clearer conversation may not mean complete recovery

Research in people with cirrhosis has found that some cognitive difficulties can remain after an overt HE episode appears to have resolved. A study using cross-sectional comparisons and a prospective group found residual problems in working memory, learning, and suppressing an inappropriate response, even when routine mental status had normalized. In another group within that study, more previous HE hospitalizations were associated with greater impairment on several tests. This helps explain why apparent conversational recovery and performance on a demanding task may differ. ³¹

The study was observational and involved selected patients. It does not show that every episode causes permanent damage, predict how an individual will recover, or provide a universal date for returning to complex activities. Its practical implication is that ongoing cognitive difficulty should not be dismissed just because obvious disorientation has cleared. Clinical follow-up can distinguish persistent problems from another episode or a different cause, and help assess which everyday activities are currently realistic. ³¹

Supporting the person without carrying everything alone

A caregiver may help notice changes, organize medicines, prepare meals, arrange transport, and describe the course of an episode to clinicians. A short shared record can make observations clearer: what changed, when it changed, and how it affected usual activities. Support works best when it is agreed with the person during a clearer period and adapted to what the household can manage. Cognitive symptoms may limit someone’s awareness of their difficulties, which can make conversations about help especially delicate. ²⁶

Altered behavior should not be treated as a moral failing or deliberate refusal to cooperate. At the same time, families should not be expected to manage complex illness without training or backup. Ask the team to explain warning signs, demonstrate practical medicine support where needed, and identify help with transport, meals, or care responsibilities. Caregivers need time to rest and opportunities to describe their own strain. Involving more than one trusted person, when possible and acceptable, can reduce reliance on a single exhausted helper. ²⁶

Recovery and future decisions

Supportive or palliative care can help with symptoms, caregiver burden, and difficult decisions alongside active liver treatment or transplant evaluation. It does not mean that treatment has been abandoned. The right support depends on what is hardest for the person and household: distressing symptoms, uncertainty, frequent hospital visits, or the practical demands of care. These concerns can be discussed before a crisis and revisited as the illness and priorities change. ²³

A period when thinking is clear is a useful opportunity to discuss preferences and identify someone who could help communicate them if decision-making becomes difficult. This can include what matters most in daily life and how the person wants information and decisions shared. Such conversations do not predict that another severe episode will occur. They reduce uncertainty if it does. One HE diagnosis cannot provide a universal life-expectancy estimate; the broader disease, available treatments, and individual goals all matter. ²³

This is general adult health education, not a personal diagnosis or prescribing plan. Children, pregnancy, and unusual causes of raised ammonia need separate specialist advice. Clinical sources were checked on 16 October 2026; this page does not claim independent clinician certification.

The original educational video is retained below as supplementary material. Its full contents and treatment currency have not been independently reviewed for this update; use the written guidance and the treating team’s instructions for current care decisions.